Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=cticLatest Financial News for Cell Therapeutics, Inc.en-usThu, 24 Dec 2009 19:46:07 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh92198_2009-12-24_19-46-07_n24190746_newsml&rpc=44&type=marketsNewsyahoo_finance/3742898519Thu, 24 Dec 2009 19:46:07 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091222/sf29518.html?.v=1Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's "Code on Interactions with Healthcare Professionals, revised July 2008" .  Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.yahoo_finance/1894191749Tue, 22 Dec 2009 06:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh54310_2009-12-21_12-20-02_sge5bk0dk_newsml&rpc=44&type=marketsNewsyahoo_finance/352041377Mon, 21 Dec 2009 12:20:02 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/sf28972.html?.v=1Cell Therapeutics, Inc. announced today that the European Medicines Agency has granted pixantrone orphan drug designation for the treatment of DLBCL which accounts for about 80% of aggressive non-Hodgkin's lymphoma.  CTI expects to file the Marketing Authorization Application in Europe for approval of pixantrone in mid-2010 and would be granted 10 year market exclusivity if it is approved.yahoo_finance/3228927849Mon, 21 Dec 2009 06:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091218/ctic8-k.htmlyahoo_finance/2484579432Fri, 18 Dec 2009 22:12:04 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12uv4f7ja/*http%3A//www.thestreet.com/_yahoo/story/10647632/1/biotech-stock-mailbag-year-in-review.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/537529219Fri, 18 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091217/ctic8-k.htmlyahoo_finance/1081132705Thu, 17 Dec 2009 21:44:54 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091217/sf27649.html?.v=1Cell Therapeutics, Inc. announced today that on February 10, 2010 the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee will review the New Drug Application for pixantrone for the treatment of relapsed/refractory aggressive non-Hodgkin's lymphoma .yahoo_finance/1746489622Thu, 17 Dec 2009 06:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13c78saj2/*http%3A//www.fool.com/investing/general/2009/12/16/3-reasons-why-you-should-ignore-everyones-predicti.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1451025755Wed, 16 Dec 2009 21:10:19 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13k7s18uq/*http%3A//www.thestreet.com/_yahoo/story/10647248/1/cell-therapeutics-gets-fda-panel-for-lymphoma-drug-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2962732608Wed, 16 Dec 2009 15:34:21 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12tiak2vi/*http%3A//www.thestreet.com/_yahoo/story/10645419/1/biotech-calendar-upcoming-fda-dates.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1361860995Tue, 15 Dec 2009 10:05:12 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1315jslb6/*http%3A//www.thestreet.com/_yahoo/story/10643058/1/biotech-stock-mailbag-cell-therapeutics.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/44584048Fri, 11 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091211/180125.html?.v=1DALLAS -- BeaconEquity.com announces an investment report featuring biopharmaceutical company Cell Therapeutics Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.yahoo_finance/3528741731Fri, 11 Dec 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12n91bqhd/*http%3A//www.fool.com/investing/options/2009/12/09/a-strategy-for-all-situations.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1550900973Wed, 9 Dec 2009 21:03:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091209/28112.html?.v=1Cell Therapeutics announced positive data from the pivotal phase III EXTEND clinical trial of pixantrone.yahoo_finance/2629820621Wed, 9 Dec 2009 16:43:05 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13570fiqj/*http%3A//www.thestreet.com/_yahoo/story/10641044/1/cell-therapeutics-on-dilution-watch-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/117008325Tue, 8 Dec 2009 19:16:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091208/sf22093.html?.v=1yahoo_finance/1423386342Tue, 8 Dec 2009 06:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091207/sf21765.html?.v=1Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology Annual Meeting updated results from the pivotal phase III EXTEND clinical trial of pixantrone in relapsed or refractory, aggressive non-Hodgkin's lymphomayahoo_finance/723578864Mon, 7 Dec 2009 06:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091202/sf19084.html?.v=1Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma at the 51st Annual Meeting of the American Society of Hematology on Saturday, December 5, 2009 in New Orleans, Louisiana.yahoo_finance/739204290Wed, 2 Dec 2009 06:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091201/sf18686.html?.v=1Cell Therapeutics, Inc. management's presentation at the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1 at 11:00 a.m. Eastern Time will be webcast live at www.celltherapeutics.com.yahoo_finance/3519743438Tue, 1 Dec 2009 06:30:00 Etc/GMT